UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Aberrant global methylation patterns affect the molecular pathogenesis and prognosis of multiple myeloma

Blood, 2011-01, Vol.117 (2), p.553-562

2011

Volltextzugriff (PDF)

PB1809: COMPARISON OF OPTICAL GENOME MAPPING WITH STANDARD OF CARE TESTING TO INVESTIGATE GENOMIC ABNORMALITIES IN HAEMATOLOGICAL MALIGNANCIES: THE EXPERIENCE OF CENTRAL AND SOUTH GENOMIC LABORATORY HUB, UK

HemaSphere, 2023-08, Vol.7 (S3), p.e89431d8-n/a

2023

Volltextzugriff (PDF)

TP53 Mutations Identified Using NGS Comprise the Overwhelming Majority of TP53 Disruptions in CLL: Results From a Multicentre Study

Frontiers in oncology, 2022-06, Vol.12, p.909615-909615

2022

Volltextzugriff (PDF)

In situ hybridisation in tissue sections

Diagnostic histopathology (Oxford, England : 2008), 2020-11, Vol.26 (11), p.521-528

Chiecchio, Laura

2020

Volltextzugriff (PDF)

Transmission of diffuse large B-cell lymphoma by an allogeneic stem-cell transplant

Haematologica (Roma), 2019-04, Vol.104 (4), p.e174-e177

2019

Volltextzugriff (PDF)

Timing of acquisition of deletion 13 in plasma cell dyscrasias is dependent on genetic context

Haematologica (Roma), 2009-12, Vol.94 (12), p.1708-1713

2009

Volltextzugriff (PDF)

The t(14;20) is a poor prognostic factor in myeloma but is associated with long-term stable disease in monoclonal gammopathies of undetermined significance

Haematologica (Roma), 2010-07, Vol.95 (7), p.1221-1225

2010

Volltextzugriff (PDF)

Gene mapping and expression analysis of 16q loss of heterozygosity identifies WWOX and CYLD as being important in determining clinical outcome in multiple myeloma

Blood, 2007-11, Vol.110 (9), p.3291-3300

2007

Volltextzugriff (PDF)

Deletions of CDKN2C in Multiple Myeloma: Biological and Clinical Implications

Clinical cancer research, 2008-10, Vol.14 (19), p.6033-6041

2008

Volltextzugriff (PDF)

Frequent upregulation of MYC in plasma cell leukemia

Genes chromosomes & cancer, 2009-07, Vol.48 (7), p.624-636

2009

Volltextzugriff (PDF)

Loss of 1p and rearrangement of MYC are associated with progression of smouldering myeloma to myeloma: sequential analysis of a single case

Haematologica (Roma), 2009-07, Vol.94 (7), p.1024-1028

2009

Volltextzugriff (PDF)

De novo Richter transformation

Blood, 2017-04, Vol.129 (17), p.2455-2455

2017

Volltextzugriff (PDF)

A novel prognostic model in myeloma based on co-segregating adverse FISH lesions and the ISS: analysis of patients treated in the MRC Myeloma IX trial

Leukemia, 2012-02, Vol.26 (2), p.349-355

2012

Volltextzugriff (PDF)

A compendium of myeloma-associated chromosomal copy number abnormalities and their prognostic value

Blood, 2010-10, Vol.116 (15), p.e56-e65

2010

Volltextzugriff (PDF)

Surface IgM expression and function are associated with clinical behavior, genetic abnormalities, and DNA methylation in CLL

Blood, 2016-08, Vol.128 (6), p.816-826

2016

Volltextzugriff (PDF)

Karyosequencing: Integrating Genome-Wide and Targeted Sequencing for Comprehensive Diagnosis of Lymphoproliferative Disorders

Blood, 2021-11, Vol.138 (Supplement 1), p.272-272

2021

Volltextzugriff (PDF)

Mapping of chromosome 1p deletions in myeloma identifies FAM46C at 1p12 and CDKN2C at 1p32.3 as being genes in regions associated with adverse survival

Clinical cancer research, 2011-12, Vol.17 (24), p.7776-7784

2011

Volltextzugriff (PDF)

Subclonal TP53 copy number is associated with prognosis in multiple myeloma

Blood, 2018-12, Vol.132 (23), p.2465-2469

2018

Volltextzugriff (PDF)

Characterisation of Long-Term Responders to First-Line Myeloma Therapy - Results from the UK Myeloma IX and XI Trials

Blood, 2018-11, Vol.132 (Supplement 1), p.2000-2000

2018

Volltextzugriff (PDF)

The clinical impact and molecular biology of del(17p) in multiple myeloma treated with conventional or thalidomide-based therapy

Genes chromosomes & cancer, 2011-10, Vol.50 (10), p.765-774

2011

Volltextzugriff (PDF)

A molecular diagnostic approach able to detect the recurrent genetic prognostic factors typical of presenting myeloma

Genes chromosomes & cancer, 2015-02, Vol.54 (2), p.91-98

2015

Volltextzugriff (PDF)

Gender Disparities in the Tumor Genetics and Clinical Outcome of Multiple Myeloma

Cancer epidemiology, biomarkers & prevention, 2011-08, Vol.20 (8), p.1703-1707

2011

Volltextzugriff (PDF)

Surface IgM Levels Independently Influence Clinical Behavior and Associate with Altered Phenotype and Genetics in Chronic Lymphocytic Leukemia

Blood, 2014-12, Vol.124 (21), p.830-830

2014

Volltextzugriff (PDF)

Heterogeneity in the prognostic significance of 12p deletion and chromosome 5 amplification in multiple myeloma

Journal of clinical oncology, 2011-01, Vol.29 (2), p.e37-e39

2011

Volltextzugriff (PDF)

1 – 25 von 40

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(36)
Mit Volltextzugriff
(37)

Publikationsform

Artikel
(39)
Dissertationen
(1)

Sprache

Englisch
(40)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(25)
Science & Technology
(25)
Humans
(24)
Aged
(14)
Biological And Medical Sciences
(14)
Female
(14)
Multiple Myeloma - Genetics
(14)
Medical Sciences
(13)
Middle Aged
(13)
Oncology
(13)
In Situ Hybridization, Fluorescence
(12)
Male
(12)
Hematology
(11)
Adult
(9)
Hematologic And Hematopoietic Diseases
(8)
Immunodeficiencies. Immunoglobulinopathies
(8)
Immunoglobulinopathies
(8)
Immunopathology
(8)
Prognosis
(8)
Aged, 80 And Over
(7)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Aberrant global methylation patterns affect the molecular pathogenesis and prognosis of multiple myeloma

PB1809: COMPARISON OF OPTICAL GENOME MAPPING WITH STANDARD OF CARE TESTING TO INVESTIGATE GENOMIC ABNORMALITIES IN HAEMATOLOGICAL MALIGNANCIES: THE EXPERIENCE OF CENTRAL AND SOUTH GENOMIC LABORATORY HUB, UK

TP53 Mutations Identified Using NGS Comprise the Overwhelming Majority of TP53 Disruptions in CLL: Results From a Multicentre Study

In situ hybridisation in tissue sections

Transmission of diffuse large B-cell lymphoma by an allogeneic stem-cell transplant

Timing of acquisition of deletion 13 in plasma cell dyscrasias is dependent on genetic context

The t(14;20) is a poor prognostic factor in myeloma but is associated with long-term stable disease in monoclonal gammopathies of undetermined significance

Gene mapping and expression analysis of 16q loss of heterozygosity identifies WWOX and CYLD as being important in determining clinical outcome in multiple myeloma

Deletions of CDKN2C in Multiple Myeloma: Biological and Clinical Implications

Frequent upregulation of MYC in plasma cell leukemia

Loss of 1p and rearrangement of MYC are associated with progression of smouldering myeloma to myeloma: sequential analysis of a single case

De novo Richter transformation

A novel prognostic model in myeloma based on co-segregating adverse FISH lesions and the ISS: analysis of patients treated in the MRC Myeloma IX trial

High Success Rates Utilizing Local Standard of Care Cytogenetic Testing for Risk Stratified Frontline Therapy for Newly Diagnosed Multiple Myeloma: Experience from the Ukmra RADAR Study

A compendium of myeloma-associated chromosomal copy number abnormalities and their prognostic value

Surface IgM expression and function are associated with clinical behavior, genetic abnormalities, and DNA methylation in CLL

Karyosequencing: Integrating Genome-Wide and Targeted Sequencing for Comprehensive Diagnosis of Lymphoproliferative Disorders

Mapping of chromosome 1p deletions in myeloma identifies FAM46C at 1p12 and CDKN2C at 1p32.3 as being genes in regions associated with adverse survival

Subclonal TP53 copy number is associated with prognosis in multiple myeloma

Characterisation of Long-Term Responders to First-Line Myeloma Therapy - Results from the UK Myeloma IX and XI Trials

The clinical impact and molecular biology of del(17p) in multiple myeloma treated with conventional or thalidomide-based therapy

A molecular diagnostic approach able to detect the recurrent genetic prognostic factors typical of presenting myeloma

Gender Disparities in the Tumor Genetics and Clinical Outcome of Multiple Myeloma

Surface IgM Levels Independently Influence Clinical Behavior and Associate with Altered Phenotype and Genetics in Chronic Lymphocytic Leukemia

Heterogeneity in the prognostic significance of 12p deletion and chromosome 5 amplification in multiple myeloma

Suchergebnisse filtern